Company Profile
The Cooper Companies Stock Price, News & Analysis
- Ticker:
- COO
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Stock performance
70.29 USD (-0.03%)
Close
Last updated: July 27, 2026
11.6B USD
Market cap
Why the stock is moving
As of Jul 27, 2026, COO was little changed and closed at $70.29. No new same-company headline was identified in the current news window.
Company overview
Business overview
CooperCompanies is a global medical device company focused on contact lenses and women’s health products. Its business combines eye-care consumables with fertility and surgical solutions.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, CooperCompanies has an international footprint across vision care and women’s health. It sits in medtech rather than biotech.
Business Model Characteristics
The business relies on recurring contact-lens demand, product innovation, and steady execution in eye care and women’s health. Investors watch volume growth, product mix, and margin trends across its two major franchises.
Position Within the Biotechnology Landscape
CooperCompanies is outside biotech but belongs in the broader healthcare innovation stack. Its stock is driven by recurring product demand and execution, not by binary clinical data.
Future catalysts
CooperCompanies’ watchlist is contact-lens growth, myopia-management adoption, and continued execution in the fertility and vision franchises. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
DNLI · Source: Denali Therapeutics
- 02
- 03
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
ICUI · Source: ICU Medical
- 04
Encompass Health increases and declares dividend on common stock
EHC · Source: Encompass Health Corporation
- 05
Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026
TCMD · Source: Tactile Systems Technology, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of The Cooper Companies (COO)?
The Cooper Companies (COO) most recently closed at 70.29 USD, a -0.03% move versus the previous session.
What is the market cap of The Cooper Companies (COO)?
The Cooper Companies currently has a market capitalization of 11.6B USD on BioPharmSignal.
What does The Cooper Companies do?
CooperCompanies is a global medical device company focused on contact lenses and women’s health products. Its business combines eye-care consumables with fertility and surgical solutions.
On which exchange is COO stock listed?
The Cooper Companies (COO) is associated with NYSE, United States, MedTech.
What is CooperCompanies?
CooperCompanies’ watchlist is contact-lens growth, myopia-management adoption, and continued execution in the fertility and vision franchises.
Which conditions is The Cooper Companies targeting with CooperCompanies?
CooperCompanies’ watchlist is contact-lens growth, myopia-management adoption, and continued execution in the fertility and vision franchises.
How does The Cooper Companies describe recent progress with CooperCompanies?
CooperCompanies’ watchlist is contact-lens growth, myopia-management adoption, and continued execution in the fertility and vision franchises.
What future catalysts are investors watching for The Cooper Companies?
CooperCompanies’ watchlist is contact-lens growth, myopia-management adoption, and continued execution in the fertility and vision franchises. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers...